Garcia Jorge E, Thiel David D, Broderick Gregory A
Department of Urology, Mayo Clinic Jacksonville, Jacksonville, Florida 32224, USA.
Can J Urol. 2007 Apr;14(2):3523-5.
Bacillus Calmette-Guerin (BCG) is a common intravesical agent utilized for superficial transitional cell carcinoma of the bladder. The potential for side effects and complications does exist secondary to the utilization of live attenuated bacteria. We present the case of a 70-year old male that developed BCG pyelonephritis and associated renal mass following the fifth of six weekly intravesical BCG therapies. The patient improved clinically and renal mass resolved following 3 months of isoniazid monotherapy without renal biopsy.
卡介苗（BCG）是用于膀胱浅表性移行细胞癌的常用膀胱内灌注药物。由于使用减毒活细菌，确实存在副作用和并发症的可能性。我们报告一例70岁男性病例，该患者在接受六次每周一次的膀胱内卡介苗治疗中的第五次治疗后，发生了卡介苗性肾盂肾炎并伴有相关肾肿块。在未进行肾活检的情况下，患者接受3个月的异烟肼单药治疗后临床症状改善，肾肿块消退。
